MLNT

Melinta Therapeutics, Inc. Common Stock

MLNT

Delisted

MLNT was delisted on the 10th of January, 2020.

Back to rankings

Healthcare Drug Manufacturers - General

Financial journalist opinion

CorMedix to Buy Melinta Therapeutics for $300 Million

The buyer said the deal adds six marketed infectious-disease products to its offerings.

CorMedix to Buy Melinta Therapeutics for $300 Million

See News Rankings

Charts implemented using Lightweight Charts™